Showing results (231-240 of 396) with videos related to

Sort By:
Pageof 40
Leukemia|May 1, 1997
Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117D Haase, M Feuring-Buske, C Schäfer, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Pathologie|August 8, 2006
New insights into the biology of acute myeloid leukemia and their impact on treatmentW Hiddemann, T Haferlach, C Schoch, et al.
Leukemia|July 1, 1997
Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genesB Linke, I Bolz, A Fayyazi, et al.
Annals of Hematology|October 1, 1993
Simultaneous administration of granulocyte colony-stimulating factor (Filgrastim) and induction chemotherapy in acute lymphoblastic leukemia. A pilot studyO G Ottmann, A Ganser, M Freund, et al.
Leukemia|April 1, 1991
Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering propertiesL W Terstappen, S Könemann, M Safford, et al.
Onkologie|June 1, 1986
High-dose cytosine-arabinoside and mitoxantrone in refractory acute myeloid leukemia: a clinical phase I/II-studyW Hiddemann, H Kreutzmann, K Straif, et al.
Cell Stress & Chaperones|February 24, 2001
Hsp70 plasma membrane expression on primary tumor biopsy material and bone marrow of leukemic patientsM Hantschel, K Pfister, A Jordan, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate in patients with advanced colorectal cancer. Results of a phase II studyC H Köhne, A Harstrick, W Hiddemann, et al.
Leukemia|October 10, 1998
Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokineticsJ Braess, M Freund, A Hanauske, et al.
Annals of Hematology|July 28, 2001
Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemiasW Kern, E Schleyer, J Braess, et al.
Pageof 40